OXIDIEN PHARMACEUTICALS Trademark

Trademark Overview


On Friday, October 6, 2023, a trademark application was filed for OXIDIEN PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the OXIDIEN PHARMACEUTICALS trademark a serial number of 98212166. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 27, 2024. This trademark is owned by Oxidien Pharmaceuticals, LLC. The OXIDIEN PHARMACEUTICALS trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, substances and products for use in nephrology and urology, namely, for the treatment and prevention of kidney-related disease, namely, kidney stones, hyperoxaluria, hyperoxalemia, and chronic kidney disease

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; scientific and technological services, namely, research and development of new products for others, and scientific research in the field of pharmaceutics, and scientific laboratory services; medical and pharmacological research services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; natural science services, namely, biological research, and chemical analysis of industrial and clinical fluids; medical and scientific research in the field of pharmaceutical preparations, and drugs; clinical testing, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; product development of probes, reagents and bioassays for industrial and scientific purposes
oxidien pharmaceuticals

General Information


Serial Number98212166
Word MarkOXIDIEN PHARMACEUTICALS
Filing DateFriday, October 6, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations, substances and products for use in nephrology and urology, namely, for the treatment and prevention of kidney-related disease, namely, kidney stones, hyperoxaluria, hyperoxalemia, and chronic kidney disease
Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
NOT AVAILABLE"PHARMACEUTICALS"
Goods and ServicesPharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; scientific and technological services, namely, research and development of new products for others, and scientific research in the field of pharmaceutics, and scientific laboratory services; medical and pharmacological research services, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; natural science services, namely, biological research, and chemical analysis of industrial and clinical fluids; medical and scientific research in the field of pharmaceutical preparations, and drugs; clinical testing, namely, scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations, and drugs; product development of probes, reagents and bioassays for industrial and scientific purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOxidien Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421

Party NameOxidien Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Tuesday, October 10, 2023NEW APPLICATION ENTERED
Saturday, October 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 10, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 28, 2024ASSIGNED TO EXAMINER
Wednesday, May 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 29, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, May 29, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT